Authors
HAI-TAO HUANG1
, YU QIAO1
, LI CHEN2
, CHUN-QIU XIA1
, CHONG-JUN ZHONG1*
Departments
1
Department of thoracic and Cardiovascular Surgery, Nantong first people’s hospital, the Second Affiliated Hospital of Nantong
University, Nantong, 226001, P.R. China - 2
Department of Pathology, Nantong University, Nantong, 226001, P.R. China
Abstract
Introduction: To investigate the effects of silencing NET-1 (neuroepithelial cell transforming gene-1) and VEGF (vascular
endothelial growth factor) using DGT siRNA (Dual genes targeting small interfering ribonucleic acid) on the biological behavior of
lung cancer cell in vivo.
Materials and methods: In this study, 12 nude mice models bearing human lung cancer xenografts were built by injecting A549
lung cancer cell. The targeting NET-1, VEGF siRNA and DGT siRNA embedded by cationic liposome were injected to the xenograft
tumor when its volume reached to 100mm3. The expressions of NET-1 and VEGF gene in xenograft tumor were detected by immunohistochemistry.
Additionally, proliferation and microvessel density of xenograft tumors were evaluated by detecting the expression of Ki-
67 and CD34 respectively.
Results: Nude mice models bearing xenograft tumor were successfully built. In dual siRNA group, compared with single NET-1
or VEGF siRNAs group, the volume of xenograft tumor was smaller; the expressions of NET-1 and VEGF was lower; the expression of
Ki-67 and CD34 was lower as well (P<0.05).
Conclusions: Dual-target genes silencing could achieve better inhibitory effects on the proliferation and the angiogenesis of
lung xenograft tumor.
Keywords
RNAi; dual-gene-targeting siRNA; NET-1; VEGF; Lung cancer
DOI:
10.19193/0393-6384_2016_1_34